Purchases and Sales Made in Q1 2024 in Nls Pharmaceutics Ltd. (NLSP)
This table provides information about the institutional ownership of Nls Pharmaceutics Ltd. (NLSP) during Q1 2024. The information is specifically focused on institutions that hold shares of NLS Pharmaceutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
2.17MNew |
$348K - $1.28M
|
2.17M
$4.11M
|
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
167K+ 1316.56% |
$26.7K - $98.5K
|
180K
$339K
|
|
|
May 13, 2024
Q1 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
25.6KNew |
$4.1K - $15.1K
|
25.6K
$48.4K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
19.2KNew |
$3.07K - $11.3K
|
19.2K
$36.3K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1New |
$0.16 - $0.59
|
1
$1.89
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|